FINHUB Insights

RMD · Q1 FY26 · Jul 1 – Sep 30, 2025

ResMed Q1 FY26: where the revenue came from and where it went

ResMed Q1 FY26: revenue $1.3B (+9% year over year). Net profit $0.3B. Largest cohort Sleep and Breathing Health $1.2B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2025
Reported
Oct 31, 2025 10-Q
Sankey diagram of ResMed's income statement for Q1 FY26: revenue of $1.3 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$1.3B +9% year over year
Gross profit$0.8B 61% margin
Operating profit$0.4B 33% margin
Net profit$0.3B 26% margin

The numbers

All figures in billions of U.S. dollars, for Q1 FY26 (period ends Sep 30, 2025).
ItemValueShare of revenueYear over year
Revenue 1.3 100% +9%
Sleep and Breathing Health 1.2 92% +10%
Residential Care Software 0.2 15% +6%
Cost of revenue−0.538%
Gross profit0.861% margin+3pp
Research & development−0.17%+0pp
SG&A−0.319%+0pp
Other−02%+0pp
Operating profit0.433% margin+2pp
Tax−0.1
Net profit0.326%+1pp
Filing on EDGAR More quarters of RMD

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters